[Other]
Molecular Detection of Minimal Residual Disease Based on NPM1-Real-Time PCR At the Time of Complete Remission Is a Strong Predictor of Disease Free and Overall Survival in AML
Authors:Christian Thiede; Nona Shayegi; Michael Kramer; Martin Bornhauser; Markus Schaich; Johannes Schetelig; Uwe Platzbecker; Christoph Rollig; Gerhard Ehninger